Kelly M. Ramsbottom

Kelly M. Ramsbottom

Auto-generated profile, based on publicly available information

Kelly M. Ramsbottom

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
CKConor Kearney
Conor Kearney
SVStephin J. Vervoort
Stephin J. Vervoort
SHSimon J. Hogg
Simon J. Hogg
KRKelly M. Ramsbottom
Kelly M. Ramsbottom
AFAndrew J. Freeman
Andrew J. Freeman
JOJane Oliaro
Jane Oliaro
Immunotherapy has revolutionized outcomes for cancer patients, but the mechanisms of resistance remain poorly defined. We used a series of whole-genome clustered regularly interspaced short palindromic repeat (CRISPR)–based screens performed in vitro and in vivo to identify mechanisms of tumor immune evasion from cytotoxic lymphocytes [CD8+ T cells and natural killer (NK) cells]. Deletion of key genes within the tumor necrosis factor (TNF) signaling, interferon-γ (IFN-γ) signaling, and antigen presentation pathways provided protection of tumor cells from CD8+ T cell–mediated killing and blunted antitumor immune responses in vivo. Deletion of a number of genes in the TNF pathway also emerged as the key mechanism of immune evasion from primary NK cells. Our screens also identified that the metabolic protein 2-aminoethanethiol dioxygenase (Ado) modulates sensitivity to TNF-mediated killing by cytotoxic lymphocytes and is required for optimal control of tumors in vivo. Remarkably, we found that tumors delete the same genes when exposed to perforin-deficient CD8+ T cells, demonstrating that the dominant immune evasion strategy used by tumor cells is acquired resistance to T cell–derived cytokine-mediated antitumor effects. We demonstrate that TNF-mediated bystander killing is a potent T cell effector mechanism capable of killing antigen-negative tumor cells. In addition to highlighting the importance of TNF in CD8+ T cell– and NK cell–mediated killing of tumor cells, our study also provides a comprehensive picture of the roles of the TNF, IFN, and antigen presentation pathways in immune-mediated tumor surveillance.

19 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
CKConor Kearney
Conor Kearney
SVStephin J. Vervoort
Stephin J. Vervoort
KRKelly M. Ramsbottom
Kelly M. Ramsbottom
ITIzabela Todorovski
Izabela Todorovski
ELEmily J. Lelliott
Emily J. Lelliott
RJRicky W. Johnstone
Ricky W. Johnstone
A new technology, SUGAR-seq, enables simultaneous detection of surface glycans, epitopes, transcripts, and TCR repertoire.